Literature DB >> 18160807

Testicular mixed germ cell tumor in an adolescent with cowden disease.

Minati Devi1, Norma Leonard, Svetlana Silverman, Mohamed Al-Qahtani, Rose Girgis.   

Abstract

Cowden disease (also known as Cowden syndrome) is characterized by multiple organ hamartomatous tumors and an increased risk of malignancy, in particular of the breast, thyroid and endometrium. Testicular tumors including seminoma have previously been reported in adult patients. We are reporting, for the first time, a case of testicular mixed germ cell tumor in an adolescent with Cowden disease. An association of testicular malignancy in Cowden disease could be explained by the previous observation of strong PTEN gene expression in the basal cell layer around seminiferous tubules and increased frequency of PTEN mutations in cultured testicular cancer cell lines. Surveillance for breast, thyroid, endometrial and renal cancer has been recommended for individuals with Cowden disease. The association of Cowden disease and testicular malignancy in our case suggests the need for additional screening of testes. (c) 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160807     DOI: 10.1159/000112825

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  3 in total

1.  Testicular pain as a presentation of Cowden syndrome.

Authors:  Hussain M Alnajjar; Arun Sahai; Andrew Keane; Stephen Gordon
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

Review 2.  Cowden syndrome: a critical review of the clinical literature.

Authors:  Robert Pilarski
Journal:  J Genet Couns       Date:  2008-10-30       Impact factor: 2.537

3.  Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients.

Authors:  Douglas L Riegert-Johnson; Ferga C Gleeson; Maegan Roberts; Krysta Tholen; Lauren Youngborg; Melvin Bullock; Lisa A Boardman
Journal:  Hered Cancer Clin Pract       Date:  2010-06-17       Impact factor: 2.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.